Compare WGS & BGSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WGS | BGSI |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.3B |
| IPO Year | 2020 | 2025 |
| Metric | WGS | BGSI |
|---|---|---|
| Price | $58.18 | $81.67 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 15 |
| Target Price | $93.50 | ★ $146.71 |
| AVG Volume (30 Days) | ★ 643.6K | 26.3K |
| Earning Date | 11-03-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 0.53% |
| EPS Growth | ★ 62.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $427,539,000.00 | N/A |
| Revenue This Year | $12.70 | $29.53 |
| Revenue Next Year | $24.31 | $8.35 |
| P/E Ratio | ★ N/A | $231.07 |
| Revenue Growth | ★ 39.97 | N/A |
| 52 Week Low | $32.21 | $75.42 |
| 52 Week High | $170.87 | $183.10 |
| Indicator | WGS | BGSI |
|---|---|---|
| Relative Strength Index (RSI) | 32.45 | 50.81 |
| Support Level | $56.36 | $75.42 |
| Resistance Level | $73.04 | $91.90 |
| Average True Range (ATR) | 5.31 | 2.50 |
| MACD | -0.35 | 0.83 |
| Stochastic Oscillator | 8.86 | 74.62 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Boyd Group Services Inc is engaged in operating non-franchised collision repair centers in North America. The Company's primary line of business is automotive collision and glass repair and related services, with the majority of revenues relating to this group of similar services. This line of business operates in Canada and the U.S. and both regions exhibit similar long-term economic characteristics. The Company is also a retail auto glass operator in the United States, under the trade names Gerber Collision & Glass, Glass America, Auto Glass Service, Auto Glass Authority. The company has majority of its sales from USA.